Matthew Ballo, MD
- Call 440.312.4700
Treatment & Services
- Body Radiosurgery
- Brachytherapy
- Cranial Radiosurgery
- External Beam Radiotherapy
- Fractionated Radiotherapy
- Gamma Knife Radiosurgery
- Hyperfractionated Radiation Therapy
- Intensity Modulated Radiation Therapy
- New Cancer Treatment Technology
- New Experimental Treatment Technologies
- Novalis Radiosurgery/Radiotherapy
- Radiotherapy
Specialty in Diseases & Conditions
- Acoustic Neuroma
- Anal Cancer
- Anaplastic Astrocytomas
- Anaplastic Oligodendrogliomas
- Bladder Cancer
- Brain Cancer
- Brain Metastases
- Colorectal Cancer
- Esophageal Cancer
- Head and Neck Cancer
- Hemangioblastomas
- Hodgkin's Disease
- Hypopharyngeal Cancer
- Large Intestine Cancer
- Laryngeal Cancer
- Lip and Oral Cavity Cancer
- Lung Cancer
- Meningioma
- Mesothelioma
- Nasal Cavity Cancer
- Nasopharyngeal Cancer
- Non-Hodgkin's Lymphoma
- Oropharyngeal Cancer
- Pancreatic Cancer
- Penile Cancer
- Pituitary Tumors
- Prostate Cancer
- Skin Cancer
- Spine Tumors
- Stomach Cancer
- Testicular Cancer
- Thymoma
- Thyroid Cancer
- Transitional Cell Cancer
- Trigeminal Neuralgia
Insurance
Is Cleveland Clinic Part of Your Insurance?
Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.
View All PlansAbout Matthew Ballo, MD
Dr. Ballo is the Vice Chair for Regional Oncology within the department of radiation oncology at Cleveland Clinic Foundation. He received his medical degree from Case Western Reserve University and medical training at MD Anderson Cancer Center. In 2006 he became the Medical Director of the MD Anderson Department of Radiation Oncology outreach program where he focused on physician professional development, education, and clinical quality assurance. He became the founding chair of Radiation Oncology for University of Tennessee in 2013 and collaborated with both academic and community-based physicians to grow coordinated clinical, research, and educational programs. He has published over 85 peer-reviewed articles and has expertise in the use of radiation for patients with central nervous system tumors, melanoma, sarcoma, and lymphoma.
Education & Professional Highlights
Appointed
2024
Education & Fellowships
Residency - MD Anderson Cancer Center
Radiation Oncology
Houston,
TX United States
2000
Internship - Mount Sinai Medical Center
Internal Medicine
Cleveland,
OH United States
1996
Medical Education - Case Western Reserve Medical School
Cleveland,
OH United States
1995
Undergraduate - Oberlin College
Biochemistry
Oberlin,
OH United States
1991
Certifications
- Radiology - Radiation Oncology
Research & Publications
See publications for Matthew Ballo, MD.
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 1/4/2025, Dr. Ballo has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.
